Opportunities for personalised follow-up in breast cancer: the gap between daily practice and recurrence risk.

Deviations from the guideline were not in line with the risk of recurrence and revealed a large gap, indicating that it is hard for clinicians to accurately estimate this risk and therefore objective risk predictions could bridge this gap.